102 related articles for article (PubMed ID: 18653998)
1. Anti-atherosclerotic activity of triacsin C, an acyl-CoA synthetase inhibitor.
Matsuda D; Namatame I; Ohshiro T; Ishibashi S; Omura S; Tomoda H
J Antibiot (Tokyo); 2008 May; 61(5):318-21. PubMed ID: 18653998
[TBL] [Abstract][Full Text] [Related]
2. Complete inhibition of mouse macrophage-derived foam cell formation by triacsin C.
Namatame I; Tomoda H; Arai H; Inoue K; Omura S
J Biochem; 1999 Feb; 125(2):319-27. PubMed ID: 9990129
[TBL] [Abstract][Full Text] [Related]
3. Triacsin C: a differential inhibitor of arachidonoyl-CoA synthetase and nonspecific long chain acyl-CoA synthetase.
Hartman EJ; Omura S; Laposata M
Prostaglandins; 1989 Jun; 37(6):655-71. PubMed ID: 2505330
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting long-chain fatty acyl CoA synthetase does not increase agonist-induced release of arachidonate metabolites from human endothelial cells.
Weis MT; Brady M; Moore M; Crumley J; Stallone JN
J Vasc Res; 2005; 42(4):275-83. PubMed ID: 15908751
[TBL] [Abstract][Full Text] [Related]
5. Triacsins, new inhibitors of acyl-CoA synthetase produced by Streptomyces sp.
Omura S; Tomoda H; Xu QM; Takahashi Y; Iwai Y
J Antibiot (Tokyo); 1986 Sep; 39(9):1211-8. PubMed ID: 3781919
[TBL] [Abstract][Full Text] [Related]
6. Evidence for an essential role of long chain acyl-CoA synthetase in animal cell proliferation. Inhibition of long chain acyl-CoA synthetase by triacsins caused inhibition of Raji cell proliferation.
Tomoda H; Igarashi K; Cyong JC; Omura S
J Biol Chem; 1991 Mar; 266(7):4214-9. PubMed ID: 1999415
[TBL] [Abstract][Full Text] [Related]
7. Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid: CoA ligases of human liver.
Vessey DA; Kelley M; Warren RS
J Biochem Mol Toxicol; 2004; 18(2):100-6. PubMed ID: 15122652
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of Cryptosporidium parvum infection in vitro and in vivo by targeting parasite fatty acyl-coenzyme A synthetases.
Guo F; Zhang H; Fritzler JM; Rider SD; Xiang L; McNair NN; Mead JR; Zhu G
J Infect Dis; 2014 Apr; 209(8):1279-87. PubMed ID: 24273180
[TBL] [Abstract][Full Text] [Related]
9. Triacsin C blocks de novo synthesis of glycerolipids and cholesterol esters but not recycling of fatty acid into phospholipid: evidence for functionally separate pools of acyl-CoA.
Igal RA; Wang P; Coleman RA
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):529-34. PubMed ID: 9182714
[TBL] [Abstract][Full Text] [Related]
10. Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C.
Kaemmerer E; Peuscher A; Reinartz A; Liedtke C; Weiskirchen R; Kopitz J; Gassler N
World J Gastroenterol; 2011 Nov; 17(44):4883-9. PubMed ID: 22171129
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of acyl-CoA synthetase by triacsins.
Tomoda H; Igarashi K; Omura S
Biochim Biophys Acta; 1987 Oct; 921(3):595-8. PubMed ID: 3117118
[TBL] [Abstract][Full Text] [Related]
12. The acyl-CoA synthetase inhibitor triacsin C enhanced eicosanoid release in leukocytes.
Oh-ishi S; Yamaki K; Abe M; Tomoda H; Omura S
Jpn J Pharmacol; 1992 Jul; 59(3):417-8. PubMed ID: 1434135
[TBL] [Abstract][Full Text] [Related]
13. Acyl-CoAs are functionally channeled in liver: potential role of acyl-CoA synthetase.
Muoio DM; Lewin TM; Wiedmer P; Coleman RA
Am J Physiol Endocrinol Metab; 2000 Dec; 279(6):E1366-73. PubMed ID: 11093925
[TBL] [Abstract][Full Text] [Related]
14. Long chain acyl coenzyme A and signaling in neutrophils. An inhibitor of acyl coenzyme A synthetase, triacsin C, inhibits superoxide anion generation and degranulation by human neutrophils.
Korchak HM; Kane LH; Rossi MW; Corkey BE
J Biol Chem; 1994 Dec; 269(48):30281-7. PubMed ID: 7982939
[TBL] [Abstract][Full Text] [Related]
15. SKI-II--a sphingosine kinase 1 inhibitor--exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet.
Potì F; Ceglarek U; Burkhardt R; Simoni M; Nofer JR
Atherosclerosis; 2015 May; 240(1):212-5. PubMed ID: 25801013
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting long chain fatty Acyl CoA synthetase increases basal and agonist-stimulated NO synthesis in endothelium.
Weis MT; Crumley JL; Young LH; Stallone JN
Cardiovasc Res; 2004 Aug; 63(2):338-46. PubMed ID: 15249192
[TBL] [Abstract][Full Text] [Related]
17. p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.
Mashima T; Oh-hara T; Sato S; Mochizuki M; Sugimoto Y; Yamazaki K; Hamada J; Tada M; Moriuchi T; Ishikawa Y; Kato Y; Tomoda H; Yamori T; Tsuruo T
J Natl Cancer Inst; 2005 May; 97(10):765-77. PubMed ID: 15900046
[TBL] [Abstract][Full Text] [Related]
18. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
[TBL] [Abstract][Full Text] [Related]
19. Lipid metabolism inhibitors of microbial origin.
Tomoda H; Omura S
Kitasato Arch Exp Med; 1993 Apr; 65 Suppl():1-12. PubMed ID: 7967370
[TBL] [Abstract][Full Text] [Related]
20. Functional effects of eggs, naturally enriched with conjugated linoleic acid, on the blood lipid profile, development of atherosclerosis and composition of atherosclerotic plaque in apolipoprotein E and low-density lipoprotein receptor double-knockout mice (apoE/LDLR-/-).
Franczyk-Zarów M; Kostogrys RB; Szymczyk B; Jawień J; Gajda M; Cichocki T; Wojnar L; Chlopicki S; Pisulewski PM
Br J Nutr; 2008 Jan; 99(1):49-58. PubMed ID: 17678565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
